247 related articles for article (PubMed ID: 31401307)
1. IL18 gene polymorphism and its influence on CD4+ T-cell recovery in HIV-positive patients receiving antiretroviral therapy.
Andrade-Santos JL; Carvalho-Silva WHV; Coelho AVC; Souto FO; Crovella S; Brandão LAC; Guimarães RL
Infect Genet Evol; 2019 Nov; 75():103997. PubMed ID: 31401307
[TBL] [Abstract][Full Text] [Related]
2. Immunological recovery failure in cART-treated HIV-positive patients is associated with reduced thymic output and RTE CD4+ T cell death by pyroptosis.
Carvalho-Silva WHV; Andrade-Santos JL; Souto FO; Coelho AVC; Crovella S; Guimarães RL
J Leukoc Biol; 2020 Jan; 107(1):85-94. PubMed ID: 31691351
[TBL] [Abstract][Full Text] [Related]
3. CCR5 genotype and pre-treatment CD4+ T-cell count influence immunological recovery of HIV-positive patients during antiretroviral therapy.
Carvalho-Silva WHV; Andrade-Santos JL; Guedes MCDS; Crovella S; Guimarães RL
Gene; 2020 May; 741():144568. PubMed ID: 32165289
[TBL] [Abstract][Full Text] [Related]
4. IL7RA polymorphisms predict the CD4+ recovery in HIV patients on cART.
Guzmán-Fulgencio M; Berenguer J; Jiménez-Sousa MA; Micheloud D; García-Álvarez M; Bellón JM; Aldámiz-Echevarría T; García-Broncano P; Catalán P; Diez C; Pineda-Tenor D; Resino S
Eur J Clin Invest; 2015 Nov; 45(11):1192-9. PubMed ID: 26402121
[TBL] [Abstract][Full Text] [Related]
5. Thymic Exhaustion and Increased Immune Activation Are the Main Mechanisms Involved in Impaired Immunological Recovery of HIV-Positive Patients under ART.
Dos Santos Guedes MC; Carvalho-Silva WHV; Andrade-Santos JL; Brelaz-de-Castro MCA; Souto FO; Guimarães RL
Viruses; 2023 Feb; 15(2):. PubMed ID: 36851655
[TBL] [Abstract][Full Text] [Related]
6. Identification of rare HIV-1-infected patients with extreme CD4+ T cell decline despite ART-mediated viral suppression.
Lisco A; Wong CS; Lage SL; Levy I; Brophy J; Lennox J; Manion M; Anderson MV; Mejia Y; Grivas C; Mystakelis H; Burbelo PD; Perez-Diez A; Rupert A; Martens CA; Anzick SL; Morse C; Chan S; Deleage C; Sereti I
JCI Insight; 2019 Apr; 4(8):. PubMed ID: 30996137
[TBL] [Abstract][Full Text] [Related]
7. The predictive role of CD4
Li CX; Li YY; He LP; Kou J; Bai JS; Liu J; Tian B; Cao LJ; Wang KH; Kuang YQ
BMC Immunol; 2019 Aug; 20(1):31. PubMed ID: 31455209
[TBL] [Abstract][Full Text] [Related]
8. Effect of Interleukin-28B polymorphism on Interleukin-28 expression and immunological recovery amongst HIV-1-infected individuals following antiretroviral therapy.
Srinidhi BV; Fletcher GJ; Sachidanantham J; Rupali P; Ramalingam VV; Demosthenes JP; Abraham OC; Pulimood SA; Rebekah G; Kannangai R
Indian J Med Microbiol; 2017; 35(4):580-584. PubMed ID: 29405153
[TBL] [Abstract][Full Text] [Related]
9. Restoration of recent thymic emigrant CD4
Barboni G; Balbaryski J; Urioste A; Candi M; Laucella S; Gaddi E
Scand J Immunol; 2020 Mar; 91(3):e12838. PubMed ID: 31630413
[TBL] [Abstract][Full Text] [Related]
10. Differences in pyroptosis of recent thymic emigrants CD4+ T Lymphocytes in ART-treated HIV-positive patients are influenced by sex.
Andrade-Santos JL; Carvalho-Silva WHV; Souto FO; Crovella S; Guimarães RL
Immunogenetics; 2021 Aug; 73(4):349-353. PubMed ID: 33449124
[TBL] [Abstract][Full Text] [Related]
11. Brief Report: Polymorphisms in TNF-α/TNFR1 Pathway Genes Are Associated With CD4+ T-Cell Recovery in HIV-1-Infected Individuals on Antiretroviral Therapy.
Celerino da Silva R; Alves NMP; Gondim Silva ML; Agrelli A; Coelho AVC; Guimarães RL; Arraes LC; Crovella S; Brandão LAC
J Acquir Immune Defic Syndr; 2021 Nov; 88(3):322-327. PubMed ID: 34267056
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism rs1385129 Within Glut1 Gene
Masson JJR; Cherry CL; Murphy NM; Sada-Ovalle I; Hussain T; Palchaudhuri R; Martinson J; Landay AL; Billah B; Crowe SM; Palmer CS
Front Immunol; 2018; 9():900. PubMed ID: 29867928
[TBL] [Abstract][Full Text] [Related]
13. Thymic Function as a Predictor of Immune Recovery in Chronically HIV-Infected Patients Initiating Antiretroviral Therapy.
Rb-Silva R; Nobrega C; Azevedo C; Athayde E; Canto-Gomes J; Ferreira I; Cheynier R; Yates AJ; Horta A; Correia-Neves M
Front Immunol; 2019; 10():25. PubMed ID: 30804925
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of HIV reservoir decay and naïve CD4 T-cell recovery between immune non-responders and complete responders on long-term antiretroviral treatment.
Zhang LX; Song JW; Zhang C; Fan X; Huang HH; Xu RN; Liu JY; Zhang JY; Wang LF; Zhou CB; Jin L; Shi M; Wang FS; Jiao YM
Clin Immunol; 2021 Aug; 229():108773. PubMed ID: 34102315
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 28B rs12979860 genotype and Human Immunodeficiency Virus type 1: Susceptibility, AIDS development and therapeutic outcome.
Zaidane I; Wakrim L; Oulad Lahsen A; Bensghir R; Chihab H; Jadid FZ; El Fihry R; Lamdini H; Fayssel N; Marhoum El Filali K; Oudghiri M; Benjelloun S; Ezzikouri S
Hum Immunol; 2018 Jan; 79(1):70-75. PubMed ID: 29080719
[TBL] [Abstract][Full Text] [Related]
16. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y
J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735
[TBL] [Abstract][Full Text] [Related]
17. Nadir CD4 T cell count as predictor and high CD4 T cell intrinsic apoptosis as final mechanism of poor CD4 T cell recovery in virologically suppressed HIV-infected patients: clinical implications.
Negredo E; Massanella M; Puig J; Pérez-Alvarez N; Gallego-Escuredo JM; Villarroya J; Villarroya F; Moltó J; Santos JR; Clotet B; Blanco J
Clin Infect Dis; 2010 May; 50(9):1300-8. PubMed ID: 20367229
[TBL] [Abstract][Full Text] [Related]
18. Impact of polymorphisms in the HCP5 and HLA-C, and ZNRD1 genes on HIV viral load.
Thørner LW; Erikstrup C; Harritshøj LH; Larsen MH; Kronborg G; Pedersen C; Larsen CS; Pedersen G; Gerstoft J; Obel N; Ullum H
Infect Genet Evol; 2016 Jul; 41():185-190. PubMed ID: 27083073
[TBL] [Abstract][Full Text] [Related]
19. Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.
Delobel P; Nugeyre MT; Cazabat M; Sandres-Sauné K; Pasquier C; Cuzin L; Marchou B; Massip P; Cheynier R; Barré-Sinoussi F; Izopet J; Israël N
J Virol; 2006 Oct; 80(20):10229-36. PubMed ID: 17005700
[TBL] [Abstract][Full Text] [Related]
20. HIV immunological non-responders are characterized by extensive immunosenescence and impaired lymphocyte cytokine production capacity.
Vos WAJW; Navas A; Meeder EMG; Blaauw MJT; Groenendijk AL; van Eekeren LE; Otten T; Vadaq N; Matzaraki V; van Cranenbroek B; Brinkman K; van Lunzen J; Joosten LAB; Netea MG; Blok WL; van der Ven AJAM; Koenen HJPM; Stalenhoef JE
Front Immunol; 2024; 15():1350065. PubMed ID: 38779686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
